A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
Anders Krarup(Oxford BioMedica (United Kingdom)), Johannes P. M. Langedijk(Janssen (Netherlands))
Cited by 387
Related Papers
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study
|The Lancet HIV|2020|91
Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer
|Nature Communications|2024|32